Otsuka Pharmaceutical Factory has signed an agreement to acquire 20% of outstanding shares in Otsuka Pharmaceutical India Private (OPI).
The shares are currently held by Claris Lifesciences, a pharmaceutical company based in India.
Based in Japan, the acquirer company manufactures and distributes industrial and pharmaceutical chemicals.
The purchase consideration for the acquisition is $20m.
German biopharmaceutical company Sygnis has agreed to acquire UK-based Innova Biosciences.
See Also:
The purchase consideration for the acquisition will include €8m ($8.79m) in cash and up to 3.5 million in shares.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData